Tissue‐resident <scp>CXCR4</scp><sup>+</sup> macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression
Zhenyu Liao(Shanghai Medical College of Fudan University), Weiding Wu(Zhejiang Provincial People's Hospital), Saimeng Shi(Shanghai Medical College of Fudan University), Long‐Yun Ye(Shanghai Medical College of Fudan University), Xianjun Yu(Fudan University Shanghai Cancer Center), Tianjiao Li(Fudan University Shanghai Cancer Center), Xuan Lin(Beijing Technology and Business University), Xing Jin(Shandong University), Huiru Zhang(Neusoft (China)), Kaizhou Jin(Shanghai Medical College of Fudan University), Qinglin Fei(Fujian Medical University)
Cited by 12
Related Papers
Ancient genomes from northern China suggest links between subsistence changes and human migration
|Nature Communications|2020|342
The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease
|Lipids in Health and Disease|2017|298
Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations
|Nature Genetics|2011|198
Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study
|The Lancet Oncology|2020|193
The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients
|Scientific Reports|2021|143